two hundred twenty-five patients with active severe rheumatoid arthritis were admitted to a multiclinic , controlled , double-blind trial comparing the use of 500 mg d-penicillamine per day , 125 mg d-penicillamine per day , and placebo .
C0003873
rheumatoid arthritis
C0030817
penicillamine